Trump Administration Files Amicus Brief Siding with Pharma Against 340B in Louisiana Federal Case
The US government filed an amicus brief in a Louisiana federal 340B case siding with pharmaceutical manufacturers, arguing states cannot enforce 340B contract pharmacy protections. Combined with a Fourth Circuit ruling blocking West Virginia's 340B law, this signals coordinated erosion of state-level 340B protections that could cost CA FQHCs millions in drug discount revenue.
Primary source
National Law ReviewFQHC Talent. (2026, April 4). Trump Administration Files Amicus Brief Siding with Pharma Against 340B in Louisiana Federal Case. Primary source: National Law Review. Retrieved June 12, 2026, from https://www.fqhctalent.com/intel/us-amicus-brief-pharma-louisiana-340b
More in Legislation
Jun 10
The work-requirement map, 6 months out: 4 states going early, Nebraska's freeze is the preview, and Georgia's 5% enrollment rate is the warning
Jun 10
MACPAC's June report hands FQHCs two federal hooks: a work-requirement monitoring mandate and a human-review requirement for AI prior-auth denials
Jun 9
Washington's 340B protection law survives — and the national map now splits clean: 22 state laws, two circuits upholding, one blocking, DOJ siding with manufacturers
Jun 5
Becerra Tops the June 2 Governor Primary and Advances to November — Putting a Former HHS Secretary in Reach of the Office, but Not Until After the December Cliff